Scarica l'app Stockscreener
2.79
2.95%
0.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché FBIO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.71
Aprire:
$2.71
Volume 24 ore:
199.67K
Relative Volume:
0.22
Capitalizzazione di mercato:
$83.02M
Reddito:
$80.97M
Utile/perdita netta:
$-78.31M
Rapporto P/E:
-0.2517
EPS:
-11.0849
Flusso di cassa netto:
$-129.56M
1 W Prestazione:
-10.29%
1M Prestazione:
-28.28%
6M Prestazione:
+91.10%
1 anno Prestazione:
+71.17%
Intervallo 1D:
$2.70
$2.80
Intervallo di 1 settimana:
$2.70
$3.24
Portata 52W:
$1.325
$4.20
Fortress Biotech Inc Stock (FBIO) Company Profile
Nome
Fortress Biotech Inc
Settore
Industria
Telefono
781-652-4500
Indirizzo
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Confronta FBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
2.79 | 80.64M | 80.97M | -78.31M | -129.56M | -11.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.20 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.85 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
553.46 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
807.98 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
330.21 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-15 | Ripresa | ROTH MKM | Buy |
| 2022-08-04 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-10-02 | Iniziato | The Benchmark Company | Buy |
| 2019-12-18 | Iniziato | B. Riley FBR | Buy |
| 2018-02-28 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-07-11 | Iniziato | Rodman & Renshaw | Buy |
| 2017-03-22 | Iniziato | JMP Securities | Mkt Outperform |
| 2016-10-03 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Fortress Biotech Inc Borsa (FBIO) Ultime notizie
Can Fortress Biotech Inc. recover in the next quarterJuly 2025 Trends & Real-Time Market Sentiment Alerts - newser.com
Real time alert setup for Fortress Biotech Inc. performanceQuarterly Earnings Summary & Smart Swing Trading Techniques - newser.com
Applying Wyckoff theory to Fortress Biotech Inc. stockRisk Management & Technical Confirmation Alerts - newser.com
Trend analysis for Fortress Biotech Inc. this weekStock Surge & Scalable Portfolio Growth Ideas - newser.com
Is Fortress Biotech Inc. stock reversal real or fakeQuarterly Earnings Summary & Verified Momentum Stock Ideas - newser.com
Fortress Biotech (NASDAQ:FBIOP) Stock Price Down 1.7% – What’s Next? - Defense World
Will Fortress Biotech Inc.(CNB0) stock beat Nasdaq index returnsGap Up & Weekly High Conviction Ideas - newser.com
Real time breakdown of Fortress Biotech Inc. stock performanceQuarterly Profit Report & Growth Focused Entry Reports - newser.com
Predicting Fortress Biotech Inc. trend using moving averagesQuarterly Market Summary & Verified Momentum Stock Alerts - newser.com
Fortress Biotech's (FBIO) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Using fundamentals and technicals on Fortress Biotech Inc.Market Volume Report & Weekly Chart Analysis and Trade Guides - newser.com
Fortress Biotech’s (FBIO) “Sell (D-)” Rating Reaffirmed at Weiss Ratings - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc.FBIO - PR Newswire
What the charts say about Fortress Biotech Inc. today2025 Trade Ideas & Verified Swing Trading Watchlist - newser.com
Will Fortress Biotech Inc. outperform the marketJuly 2025 Selloffs & Intraday High Probability Setup Alerts - newser.com
What data driven models say about Fortress Biotech Inc.’s future2025 Market Sentiment & Safe Entry Trade Reports - newser.com
Real time social sentiment graph for Fortress Biotech Inc.2025 Key Highlights & Detailed Earnings Play Alerts - newser.com
Tools to monitor Fortress Biotech Inc. recovery probability2025 Top Gainers & Daily Profit Maximizing Tips - newser.com
Revenues Working Against Fortress Biotech, Inc.'s (NASDAQ:FBIO) Share Price Following 26% Dive - simplywall.st
What catalysts could drive Fortress Biotech Inc. stock higherWeekly Stock Recap & Weekly High Return Forecasts - newser.com
Published on: 2025-10-05 05:38:39 - newser.com
What insider purchases suggest about Fortress Biotech Inc.(CNB0) stockJuly 2025 Fed Impact & Weekly High Return Opportunities - newser.com
Fortress Biotech, Inc. Securities Lawsuit Investigation - Claim Depot
Leading vs lagging indicators on Fortress Biotech Inc. performance2025 Analyst Calls & Reliable Volume Spike Alerts - newser.com
Will Fortress Biotech Inc.(CNB0) stock outperform foreign stocks2025 Technical Overview & Weekly High Return Stock Forecasts - newser.com
Published on: 2025-10-03 04:06:28 - newser.com
Applying Elliott Wave Theory to Fortress Biotech Inc.Weekly Stock Analysis & Free Fast Gain Swing Trade Alerts - newser.com
Head to Head Analysis: Fortress Biotech (NASDAQ:FBIO) & Amarin (NASDAQ:AMRN) - Defense World
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics $205 Million Series a Financing - MarketScreener
Big Announcements Hammer Biotech And AI Shares - Finimize
Fortress Biotech Investigated by the Portnoy Law Firm - GlobeNewswire
Fortress Biotech Investigated by the Portnoy Law Firm - GlobeNewswire Inc.
Why Is Fortress Biotech Stock Falling Today? - NewsBreak: Local News & Alerts
INVESTOR ALERT: Investigation of Fortress Biotech, Inc. (FBIO) Announced by Holzer & Holzer, LLC - GlobeNewswire
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility - MarketScreener
Fortress Biotech shares tumble after FDA rejection of Menkes treatment - MSN
US FDA declines to approve Fortress Bio and Zydus' treatment for a rare pediatric disease - Reuters
Fortress Biotech stock plummets after FDA rejects Menkes disease drug By Investing.com - Investing.com South Africa
Fortress Biotech Inc Azioni (FBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):